Reduced CR1 expression on aged human erythrocytes: immuno-electron microscopic and functional analysis

Area of Science:

• Immunology
• Hematology
• Cell Biology

Background:

• Erythrocyte clearance involves immune and non-immune mechanisms.
• Complement activation and C3b deposition on aged erythrocytes (AE) facilitate their removal.
• Complement receptor type 1 (CR1, CD35) on erythrocytes binds C3b, aiding C3b inactivation by factor I and protecting cells.

Purpose of the Study:

• To investigate the quantitative expression of CR1 (CD35) on aged human erythrocytes (AE) compared to young erythrocytes (YE).
• To correlate CR1 expression levels with complement regulatory functions and erythrocyte sensitivity to lysis.
• To visualize CR1 distribution on AE and YE using immune-electron microscopy.

Main Methods:

• Haemagglutination and binding assays to quantify CR1 (CD35) on AE and YE.
• Assays to measure CR1-like factor I co-factor activity.
• In vivo complement component deposition analysis (C3, C4, properdin).
• In vitro complement-mediated lysis assays.
• Immune-electron microscopy to visualize CR1 expression and distribution.

Main Results:

• AE express significantly fewer CR1 (CD35) molecules than YE.
• Reduced CR1 on AE correlates with diminished factor I co-factor activity.
• AE show increased deposition of C3, C4, and properdin in vivo.
• AE exhibit heightened sensitivity to lysis by homologous and heterologous complement in vitro.
• Immune-electron microscopy confirmed quantitative differences in CR1 expression between AE and YE.
• CR1 (CD35) arrangement on the erythrocyte surface is similar in both AE and YE.

Conclusions:

• Aging human erythrocytes exhibit a significant reduction in CR1 (CD35) expression.
• Decreased CR1 levels impair complement regulation, leading to increased C3b deposition and susceptibility to complement-mediated lysis.
• These findings underscore the role of CR1 in the clearance mechanisms of aged erythrocytes.